Company:  VERONA PHARMA PLC (VRNA)
Form Type:  8-K
Filing Date:  8/12/2022 
CIK:  0001657312 
Address:  3 MORE LONDON RIVERSIDE 
City, State, Zip:  LONDON,  SE1 2RE 
Telephone:  011-44-0-2032834200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$22.32  
Change: 
0.00 (0.00%)  
Trade Time: 
Feb 07  
Market Cap: 
$13.50B
Trade VRNA now with 

© 2023  
Description of Business
We were incorporated in February 2005 under the laws of England and Wales with the Registrar of Companies of England and Wales under the name Isis Resources plc. In September 2006, we acquired Rhinopharma Limited, a private company incorporated in Canada, and changed our name to Verona Pharma plc. Our principal office is located at 3 More London Riverside, London SE1 2RE, United Kingdom, and our telephone number is +(44) 203 283 4200. The principal legislation under which we operate is the Companies Act 2006. Our agent for service of process in the United States is Cogency Global Inc., whose address is 10 E. 40th Street, 10th floor, New York, New York 10016. Our principal capital expenditures for the year ended December 31, 2019 were £0.3 million (2018: £0.3 million, 2017: £0.2 million). These capital expenditures primarily consisted of patent costs.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 1.1
    Signature
    Directors, Officers and Others
  EXHIBIT 5.1

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.